Literature DB >> 13539019

The inhibition of plasmin by toxic phosphorus compounds.

L A MOUNTER, B A SHIPLEY.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN/antagonists; ISOFLUROPHATE/effects

Mesh：

Substances：

Year:  1958        PMID： 13539019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  6 in total

1.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors:  O D RATNOFF; E W DAVIE; D L MALLETT
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

2.  The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.

Authors:  A P Kaplan; E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

3.  In vitro thrombolytic activity of purified streptokinase extracted from Streptococcus equinus VIT_VB2 isolated from bovine milk.

Authors:  Vaishnavi Babu; C Subathra Devi
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

4.  Streptokinase production from Streptococcus dysgalactiae subsp. equisimilis SK-6 in the presence of surfactants, growth factors and trace elements.

Authors:  Shilpi Bhardwaj; Jayaraman Angayarkanni
Journal:  3 Biotech       Date:  2014-03-20       Impact factor: 2.406

5.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

6.  A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.

Authors:  B U Wintroub; E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.